In the BioHarmony Drug Report Database

"Preview" Icon

Propofol

Diprivan (propofol) is a small molecule pharmaceutical. Propofol was first approved as Diprivan on 1989-10-02. It is used to treat delirium, pain, psychomotor agitation, and status epilepticus in the USA. It is known to target potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 and ferritin light chain. Propofol’s patent is valid until 2024-12-01 (FDA).

 

Trade Name

 

Diprivan
 

Common Name

 

propofol
 

ChEMBL ID

 

CHEMBL526
 

Indication

 

delirium, pain, psychomotor agitation, status epilepticus
 

Drug Class

 

Image (chem structure or protein)

Propofol structure rendering